Effectiveness and safety of ustekinumab in inflammatory bowel disease: a systematic review and meta-analysis
S Honap, S Meade, H Ibraheim, PM Irving… - Digestive Diseases and …, 2022 - Springer
Introduction Ustekinumab, an interleukin-12 and interleukin-23 antagonist, is licensed for the
treatment of Crohn's disease (CD) and ulcerative colitis (UC) after the phase III trial …
treatment of Crohn's disease (CD) and ulcerative colitis (UC) after the phase III trial …
Precision medicine and drug optimization in adult inflammatory bowel disease patients
S Vieujean, E Louis - Therapeutic Advances in …, 2023 - journals.sagepub.com
Inflammatory bowel diseases (IBD) encompass two main entities including ulcerative colitis
and Crohn's disease. Although having a common global pathophysiological mechanism …
and Crohn's disease. Although having a common global pathophysiological mechanism …
Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register
J Thunberg, O Björkqvist, CRH Hedin… - United European …, 2022 - Wiley Online Library
Background Real‐world data on clinical outcomes of ustekinumab in ulcerative colitis are
lacking. Objective To assess short‐and long‐term clinical outcomes of ustekinumab in …
lacking. Objective To assess short‐and long‐term clinical outcomes of ustekinumab in …
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
M Fumery, J Filippi, V Abitbol, A Biron… - Alimentary …, 2021 - Wiley Online Library
Background Phase III trials have demonstrated the efficacy and safety of ustekinumab in
ulcerative colitis (UC), but few real‐life long‐term data are currently available. Aims To …
ulcerative colitis (UC), but few real‐life long‐term data are currently available. Aims To …
Effectiveness and safety of ustekinumab in ulcerative colitis: real-world evidence from the ENEIDA registry
M Chaparro, A Garre, M Iborra… - Journal of Crohn's …, 2021 - academic.oup.com
Abstract Background and Aims The development programm UNIFI has shown promising
results of ustekinumab in ulcerative colitis [UC] treatment which should be confirmed in …
results of ustekinumab in ulcerative colitis [UC] treatment which should be confirmed in …
Meta‐analysis: Real‐world effectiveness and safety of ustekinumab in patients with ulcerative colitis
C Taxonera, D Olivares… - Alimentary …, 2023 - Wiley Online Library
Background Evidence on real‐world outcomes of ustekinumab for ulcerative colitis (UC)
patients is needed. Aims To summarise evidence on the real‐world outcomes of …
patients is needed. Aims To summarise evidence on the real‐world outcomes of …
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
MF Chiappetta, A Viola, M Mastronardi… - Expert Opinion on …, 2021 - Taylor & Francis
Background Efficacy and safety of ustekinumab for the treatment of ulcerative colitis (UC)
has been demonstrated in clinical trials, but few real-world data are available so far. The aim …
has been demonstrated in clinical trials, but few real-world data are available so far. The aim …
[PDF][PDF] Predictors and outcomes of ustekinumab dose intensification in ulcerative colitis: a multicenter cohort study
Study Design This retrospective cohort study included adults with UC (ICD-10-CM 51x)
initiating ustekinumab at Brigham and Women's Hospital, Massachusetts General Hospital …
initiating ustekinumab at Brigham and Women's Hospital, Massachusetts General Hospital …
Inflammatory indexes for assessing the severity and disease progression of ulcerative colitis: a single-center retrospective study
H Lin, Z Bai, Q Wu, G Chu, Y Zhang, X Guo… - Frontiers in Public …, 2022 - frontiersin.org
Background Active and severe ulcerative colitis (UC) and non-response to 5-aminosalicylic
acid (5-ASA) are related to poor outcomes and should be accurately identified. Several …
acid (5-ASA) are related to poor outcomes and should be accurately identified. Several …
[HTML][HTML] Integrating evidence to guide use of biologics and small molecules for inflammatory bowel diseases
Advances in science have led to the development of multiple biologics and small molecules
for the treatment of inflammatory bowel diseases (IBDs). This growth in advanced medical …
for the treatment of inflammatory bowel diseases (IBDs). This growth in advanced medical …